Dipivefrine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| [2-(2,2-dimethylpropanoyloxy)-4- (1-hydroxy-2-methylamino-ethyl)- phenyl] 2,2-dimethylpropanoate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a686005 |
| Pregnancy cat. | B(US) |
| Legal status | ? |
| Identifiers | |
| CAS number | 52365-63-6  |
| ATC code | S01EA02 |
| PubChem | CID 3105 |
| DrugBank | APRD00930 |
| ChemSpider | 2994 |
| UNII | 8Q1PVL543G |
| KEGG | D02349 |
| ChEBI | CHEBI:4646 |
| ChEMBL | CHEMBL1201262  |
| Chemical data | |
| Formula | C19H29NO5 |
| Mol. mass | 351.437 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Dipivefrine is a prodrug of epinephrine used to treat glaucoma. It is available as ophthalmic solution. It causes vasoconstriction, decreased aqueous humor production, and decreases intraoccular pressure. It is converted to epinephrine upon penetration of the cornea.
[edit] References
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (March 2010) |
|
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
